Previous 10 | Next 10 |
2023-07-19 07:30:00 ET Summary At Laughing Water Capital, our interests are fully aligned with our partners as nearly all of our personal wealth is invested in our strategy. In the second quarter of 2023, Laughing Water Capital returned approximately 13.8% after all fees and expen...
- Enzo Life Sciences reports revenue of $7.5 million, with margin improvement in Q3 FY23 FARMINGDALE, NY, June 14, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a pioneering biosciences and diagnostics company, today filed its Form 10-Q for the third quarter ended April 30, 2...
2023-06-07 10:24:27 ET Major earnings expected before the bell on Thursday include: Designer Brands ( DBI ) FuelCell Energy ( FCEL ) Hyzon Motors ( HYZN ) Signet Jewelers ( SIG ) The Toro ( TTC ) For further details see: Notable earnings b...
The law firm of Federman & Sherwood has initiated an investigation into Enzo Biochem with respect to their recent data breach. On May 30, 2023, Enzo Biochem notified 2.47 million patients that the company experienced a data breach after an unauthorized party accessed sensitive consumer data e...
2023-05-26 08:13:20 ET Enzo Biochem ( NYSE: ENZ ) has filed for a $150M mixed shelf securities offering. The filing does not necessarily indicate that a sale has begun or will occur in the future. The company plans to use the proceeds for general corporate purposes. ...
FARMINGDALE, NY, May 22, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), announced today that the preliminary voting results from the Inspector of Election at today’s Special Meeting of the Shareholders indicate that the Asset Sale Proposal was approved by the affirmative vot...
FARMINGDALE, NY, April 24, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo Biochem” or the “Company”), a leading biosciences and diagnostics company, today announced that its special meeting of shareholders (the “Special Meeting”) to consid...
2023-04-14 06:57:11 ET Enzo Biochem ( NYSE: ENZ ) shed ~2% pre-market Friday after announcing a ransomware attack that has compromised the company’s IT systems and led to the extraction of certain data. The company also warned that risks and uncertainties remain due...
2023-03-21 10:03:03 ET Enzo Biochem press release ( NYSE: ENZ ): Q2 GAAP EPS of -$0.23. Revenue of $16.34M (-52.0% Y/Y). For further details see: Enzo Biochem GAAP EPS of -$0.23, revenue of $16.34M
- Company entered into an Asset Purchase Agreement for substantially all of the operating assets of the Clinical Labs division - Enzo Life Sciences reports revenue of $7.5 million, with Jan-23 revenue of $3.6M as the second highest monthly revenue in over 10 years FARMINGDALE, N...
News, Short Squeeze, Breakout and More Instantly...
Enzo Biochem Inc. Company Name:
ENZ Stock Symbol:
NYSE Market:
Shares of PriceSmart, Inc. (NASDAQ: PSMT) rose sharply in today’s pre-market trading as the company posted better-than-expected earnings for...
FARMINGDALE, N.Y., March 13, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the second quarter ended January 31, 2024. Second Quarter Highlights The Company's Life Science division's...
FARMINGDALE, NY, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading life science company, announced the voting results from its Annual Meeting held on January 31, 2024 and officer appointments. Summary of the Fis...